Microcytic Indices with Normal Hemoglobin and Elevated Ferritin: Beta-Thalassemia Trait
This patient most likely has beta-thalassemia trait, and the appropriate management is hemoglobin electrophoresis (HPLC) for definitive diagnosis, genetic counseling if confirmed, and avoidance of unnecessary iron supplementation.
Diagnostic Reasoning
Key Laboratory Pattern Analysis
The constellation of findings strongly suggests beta-thalassemia trait rather than iron deficiency:
- Elevated RBC count (5.53 million/cu.mm) with microcytosis (MCV 78 fL) and low MCH (24.4 pg) is characteristic of thalassemia trait, where patients produce more red cells to compensate for ineffective hemoglobin production 1
- Normal-to-elevated ferritin (174 µg/L) definitively excludes iron deficiency anemia, which would show ferritin <15 µg/L 2, 3
- Normal hemoglobin (135 g/L) indicates this is a trait rather than a more severe hemoglobinopathy 1
Discriminant Index Application
The Mentzer Index (MCV/RBC = 78/5.53 = 14.1) is >13, which actually suggests iron deficiency by traditional criteria. However, this must be interpreted in context of the elevated ferritin 4. The guidelines specifically note that elevation of ferritin in combination with microcytosis suggests a genetic disorder of iron metabolism or heme synthesis rather than nutritional deficiency 5.
More sophisticated indices like the CRUISE index have shown 90% accuracy in distinguishing beta-thalassemia trait from iron deficiency, with superior performance to older indices 4.
Diagnostic Workup
Essential Next Step
- High-performance liquid chromatography (HPLC) to measure HbA2 levels is the definitive diagnostic test 1, 6
- HbA2 >4.0% confirms beta-thalassemia trait 1
- Expected HbA2 range in beta-thalassemia trait: 5.57% ± 0.73% 4
Additional Considerations
- Family screening should be performed if beta-thalassemia trait is confirmed, as there is a 25% risk of beta-thalassemia major offspring when both parents are carriers 1
- Transferrin saturation may provide additional diagnostic clarity in cases where genetic disorders of iron metabolism are suspected 5
Management Approach
Critical Pitfall to Avoid
Do not prescribe iron supplementation in this patient. The elevated ferritin excludes iron deficiency, and patients with genetic anemias like sideroblastic anemia can develop severe iron overload leading to significant morbidity and mortality if inappropriately treated with iron 5.
Appropriate Management
- No treatment required for beta-thalassemia trait itself, as most carriers are asymptomatic or have only mild anemia 1
- Genetic counseling is essential, particularly for reproductive planning, to understand the 25% risk of beta-thalassemia major and 50% risk of carrier offspring when both partners are carriers 1
- Partner screening should be offered if the patient is of reproductive age 1
- Avoid misdiagnosis as iron deficiency, which leads to unnecessary invasive tests, costly diagnostics, and potentially harmful iron therapy 5